BCL9 transcription coactivator
| GO Term | Evidence Code | PMID |
|---|---|---|
| transcription by RNA polymerase II | ||
| myotube differentiation involved in skeletal muscle regeneration | ||
| regulation of transforming growth factor beta receptor signaling pathway | ||
| somatic stem cell population maintenance | ||
| skeletal muscle cell differentiation |
| GO Term | Evidence Code | PMID |
|---|---|---|
| nucleoplasm | ||
| cis-Golgi network | ||
| sarcoplasm | ||
| beta-catenin-TCF complex | ||
| beta-catenin-TCF complex |
| GO Term | Evidence Code | PMID |
|---|---|---|
| transcription coactivator activity | ||
| protein binding | ||
| beta-catenin binding |
| Gene Ontology |
|---|
| beta-catenin binding |
| canonical Wnt signaling pathway |
| InterPro |
|---|
| B Cell Lymphoma 9 |
| B-cell lymphoma 9, beta-catenin binding domain |
| Zinc finger, RING/FYVE/PHD-type |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026